Editorial context
How to use this collection
These 1 reviewed record are associated with Nigeria in the available source metadata. Country labels may describe the study setting, author affiliation, or source context, so confirm the original paper before making jurisdiction-specific conclusions.
What is included
- The normalized country label is Nigeria.
- Unknown or ambiguous country values are omitted.
- Local policy and population differences still require separate review.
Continue exploring: Browse topics · Search evidence
ClinicalTrials.gov / 2020 / Nigeria
This pilot study aims to identify patient and healthcare worker needs related to Sickle Cell Disease (SCD) management in Nigeria. It involves questionnaires for patients/parents and healthcare professionals, plus focus..